0001806540-26-000001.txt : 20260625 0001806540-26-000001.hdr.sgml : 20260625 20260625143528 ACCESSION NUMBER: 0001806540-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260625 DATE AS OF CHANGE: 20260625 EFFECTIVENESS DATE: 20260625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lycia Therapeutics, Inc. CENTRAL INDEX KEY: 0001806540 ORGANIZATION NAME: EIN: 843860514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-588627 FILM NUMBER: 261120687 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 392-3357 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001806540 Lycia Therapeutics, Inc. 400 EAST JAMIE COURT, SUITE 200 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (650) 392-3357 DELAWARE None None Corporation true William Rieflin 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Clare Ozawa 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Ming Fang 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Laurent Fischer 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Tim Anderson 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Aetna Wun Trombley 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Amy Bachrodt 400 East Jamie Court, Suite 200 South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2026-06-10 false true false 0 75000000 75000000 0 false 16 0 0 0 false Lycia Therapeutics, Inc. Aetna Wum Trombley Aetna Wun Trombley Chief Executive Officer 2026-06-24